Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis

Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis

Psoriatic arthritis (PsA) is a chronic immune-mediated disease from a group of spondyloarthritis, which is characterized by damage to the musculoskeletal system with a wide range of different clinical manifestations and is usually associated with psoriasis. Activation of the interleukin (IL) 23/IL17...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Dadalova, E. A. Vasilenko, R. R. Samigullina, V. I. Mazurov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-11-01
Series:Современная ревматология
Subjects:
psoriatic arthritis
uveitis
ixekizumab
Online Access:https://mrj.ima-press.net/mrj/article/view/1085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items